<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001995601</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>2</amendmentNo>
      <securitiesClassTitle>American Depository Shares, each of which represent twenty ordinary shares, no par value</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>02/10/2026</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001534248</issuerCik>
        <issuerName>Chemomab Therapeutics Ltd.</issuerName>
        <issuerCusip>36322Q107</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>KIRYAT ATIDIM, BUILDING 7</com:street1>
          <com:city>TEL AVIV</com:city>
          <com:stateOrCountry>L3</com:stateOrCountry>
          <com:zipCode>6158101</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Otto Erik</reportingPersonName>
      <citizenshipOrOrganization>Z4</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>385000.00</soleVotingPower>
        <soleDispositivePower>385000.00</soleDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>385000.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>6.3</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>*Percent of class represented by Row (11) based on 6,155,117 ADSs outstanding as of November 20th, 2025 (As provided by the Issuer)</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Chemomab Therapeutics Ltd.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>KIRYAT ATIDIM, BUILDING 7, TEL AVIV, ISRAEL, 6158101</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Erik Otto</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>144 West Oakview Place, San Antonio, TX 78209</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Canada</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>385,000</amountBeneficiallyOwned>
        <classPercent>6.3%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>385,000</solePowerOrDirectToVote>
          <solePowerOrDirectToDispose>385,000</solePowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under &amp;#167; 240.14a-11.

</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Otto Erik</reportingPersonName>
      <signatureDetails>
        <signature>Erik Otto</signature>
        <title>Individual</title>
        <date>02/10/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
